Top-News

Meiragtx Holdings News

Aktie
WKN:  A2JGHF ISIN:  KYG596651029 US-Symbol:  MGTX
4,54 €
-0,10 €
-2,16%
31.05.24 21:44:14
Handeln Depot/Watchlist
Aktienanzahl *
-
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-

Meiragtx Holdings News

21.12.23 - PR Newswire
Thinking about buying stock in Hookipa Pharma, Riot Platforms, Celestica, Mesoblast, or MeiraGTx?
Thinking about buying stock in Hookipa Pharma, Riot Platforms, Celestica, Mesoblast, or MeiraGTx? PR Newswire
31.10.23 - PR Newswire
Thinking about buying stock in T2 Biosystems, Cybin, Alphabet Inc, Archer Aviation, or MeiraGTx Holdings?
Thinking about buying stock in T2 Biosystems, Cybin, Alphabet Inc, Archer Aviation, or MeiraGTx Holdings? PR Newswire
28.09.21 - GlobeNewswire
MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines Conference
LONDON and NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
09.09.21 - GlobeNewswire
MeiraGTx Announces Data at EURETINA 2021 Virtual Meeting Demonstrating Reversal of Disease Progression Following Treatment with AAV5-RPGR in X-Linked Retinitis Pigmentosa
LONDON and NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.08.21 - GlobeNewswire
MeiraGTx Reports Second Quarter 2021 Financial and Operational Results
LONDON and NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.05.21 - GlobeNewswire
MeiraGTx Reports First Quarter 2021 Financial and Operational Results
LONDON and NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
05.05.21 - GlobeNewswire
MeiraGTx Announces Participation at Upcoming Investor Conferences
LONDON and NEW YORK, May 05, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
19.04.21 - GlobeNewswire
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
LONDON and NEW YORK, April 19, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
11.03.21 - GlobeNewswire
MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
-  Preparing to Initiate Phase 3 Lumeos Clinical Trial in AAV-RPGR -  Announced Positive Preliminary Clinical Data from AQUAx AAV-hAQP1 Phase 1 Trial for Treatment of Grade 2/3 ...
26.01.21 - GlobeNewswire
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
LONDON and NEW YORK, Jan. 26, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
16.12.20 - GlobeNewswire
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET
30.11.20 - GlobeNewswire
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
LONDON and NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
23.11.20 - GlobeNewswire
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
LONDON and NEW YORK, Nov. 23, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
19.11.20 - GlobeNewswire
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
LONDON and NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
18.11.20 - GlobeNewswire
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
LONDON and NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today ...
13.11.20 - GlobeNewswire
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
Data presented at AAO 2020 Virtual Annual Meeting show sustained improvements in retinal sensitivity at 12 months
10.11.20 - GlobeNewswire
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
LONDON and NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...
05.11.20 - GlobeNewswire
MeiraGTx Reports Third Quarter 2020 Financial Results
MeiraGTx preparing to initiate Phase 3 trial of AAV-RPGR Plasmid production facility expected to be completed year-end 2020 LONDON and NEW YORK,, Nov. 05, 2020 (GLOBE ...
03.10.20 - GlobeNewswire
MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)
Data presented a t EURETINA 2020 Virtual Congress show sustained improvements in retinal sensitivity at nine months S ignificant improvement s were also demonstrated in the ...
28.09.20 - GlobeNewswire
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
LONDON and NEW YORK, Sept. 28, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today ...

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »